{
    "id": 9889,
    "fullName": "ROS1 L1982F",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "ROS1 L1982F lies within the protein kinase domain of the Ros1 protein (UniProt.org). L1982F has been demonstrated to confer resistance to Ros1 tyrosine kinase inhibitors in the context of a Ros1 fusion in culture (PMID: 25351743, PMID: 24218589), but has not been biochemically characterized and therefore, its effect on Ros1 protein function is unknown (PubMed, Feb 2020).",
            "references": [
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 3476,
                    "pubMedId": 24218589,
                    "title": "Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteins.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24218589"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 3339,
                    "pubMedId": 25351743,
                    "title": "Cabozantinib overcomes crizotinib resistance in ROS1 fusion-positive cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25351743"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 6098,
        "geneSymbol": "ROS1",
        "terms": [
            "ROS1",
            "c-ros-1",
            "MCF3",
            "ROS"
        ]
    },
    "variant": "L1982F",
    "createDate": "08/01/2015",
    "updateDate": "02/21/2020",
    "referenceTranscriptCoordinates": {
        "id": 102377,
        "transcript": "NM_002944",
        "gDna": "chr6:g.117318247C>A",
        "cDna": "c.5946G>T",
        "protein": "p.L1982F",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 2810,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells overexpressing ROS1 L1982F in the context of GOPC-ROS1 (referred to as FIG-ROS1) were resistant to Xalkori (crizotinib)-mediated growth inhibition in culture (PMID: 24218589).",
            "molecularProfile": {
                "id": 10699,
                "profileName": "GOPC - ROS1 ROS1 L1982F"
            },
            "therapy": {
                "id": 706,
                "therapyName": "Crizotinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 3476,
                    "pubMedId": 24218589,
                    "title": "Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteins.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24218589"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 2814,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Foretinib (GSK1363089) inhibited growth of transformed cells expressing ROS1 L1982F in the context of GOPC-ROS1 (referred to as FIG-ROS1) in culture (PMID: 24218589).",
            "molecularProfile": {
                "id": 10699,
                "profileName": "GOPC - ROS1 ROS1 L1982F"
            },
            "therapy": {
                "id": 743,
                "therapyName": "Foretinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3476,
                    "pubMedId": 24218589,
                    "title": "Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteins.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24218589"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 9885,
            "profileName": "ROS1 L1982F",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 9886,
            "profileName": "CD74 - ROS1 ROS1 L1982F",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 10699,
            "profileName": "GOPC - ROS1 ROS1 L1982F",
            "profileTreatmentApproaches": [
                {
                    "id": 16943,
                    "name": "Foretinib",
                    "profileName": "GOPC - ROS1 ROS1 L1982F"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 102376,
            "transcript": "XM_017011172",
            "gDna": "chr6:g.117318208_117318210delCAGinsAAA",
            "cDna": "c.5944_5946delCTGinsTTT",
            "protein": "p.L1982F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 102377,
            "transcript": "NM_002944",
            "gDna": "chr6:g.117318247C>A",
            "cDna": "c.5946G>T",
            "protein": "p.L1982F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}